• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.韩国人免疫缺陷病毒/结核分枝杆菌合并感染患者中耐多药结核病的比例。
J Korean Med Sci. 2012 Oct;27(10):1143-6. doi: 10.3346/jkms.2012.27.10.1143. Epub 2012 Oct 2.
2
Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?多重耐药结核病在韩国艾滋病毒感染患者中更普遍吗?
Yonsei Med J. 2016 Nov;57(6):1508-10. doi: 10.3349/ymj.2016.57.6.1508.
3
Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.在哈萨克斯坦,HIV 感染与耐多药结核病之间虽存在趋同的风险因素,但并无关联。
Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.
4
Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.印度北部 HIV 血清阳性和血清阴性肺结核患者分离的结核分枝杆菌多药耐药情况。
BMC Infect Dis. 2013 Mar 15;13:137. doi: 10.1186/1471-2334-13-137.
5
Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam.越南胡志明市结核分枝杆菌/人类免疫缺陷病毒合并感染患者的耐药性和结核分枝杆菌株多样性。
J Glob Antimicrob Resist. 2017 Sep;10:154-160. doi: 10.1016/j.jgar.2017.07.003. Epub 2017 Jul 22.
6
Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China.中国广西感染 HIV 的患者中的结核分枝杆菌和非结核分枝杆菌分离株。
Int J Tuberc Lung Dis. 2011 Dec;15(12):1669-75. doi: 10.5588/ijtld.11.0036.
7
Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.埃塞俄比亚西北部耐多药结核病的危险因素:一项病例对照研究。
Transbound Emerg Dis. 2019 Jul;66(4):1611-1618. doi: 10.1111/tbed.13188. Epub 2019 Apr 15.
8
Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.博茨瓦纳人类免疫缺陷病毒对早期耐多药结核病治疗结局的影响。
Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.
9
Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.柬埔寨金边一家国家级转诊医院中感染艾滋病毒患者的耐药结核病情况。
Glob Health Action. 2015 Jan 22;8:25964. doi: 10.3402/gha.v8.25964. eCollection 2015.
10
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.来自埃塞俄比亚的耐多药结核病疑似患者中结核分枝杆菌菌株的耐药模式及相关危险因素。
PLoS One. 2018 Jun 4;13(6):e0197737. doi: 10.1371/journal.pone.0197737. eCollection 2018.

引用本文的文献

1
Molecular detection of rifampicin-resistant by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚通过聚合酶链反应对耐利福平情况进行分子检测:一项系统评价与荟萃分析
Front Med (Lausanne). 2024 Jun 7;11:1319845. doi: 10.3389/fmed.2024.1319845. eCollection 2024.
2
A systematic review and meta-analysis on the correlation between HIV infection and multidrug-resistance tuberculosis.一项关于HIV感染与耐多药结核病之间相关性的系统评价和荟萃分析。
Heliyon. 2023 Nov 7;9(11):e21956. doi: 10.1016/j.heliyon.2023.e21956. eCollection 2023 Nov.
3
Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients.HIV/结核病合并感染患者中耐多药结核病的患病率
Infect Chemother. 2021 Dec;53(4):792-795. doi: 10.3947/ic.2021.0085. Epub 2021 Dec 7.
4
Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?多重耐药结核病在韩国艾滋病毒感染患者中更普遍吗?
Yonsei Med J. 2016 Nov;57(6):1508-10. doi: 10.3349/ymj.2016.57.6.1508.

本文引用的文献

1
HIV and tuberculosis: a deadly human syndemic.艾滋病毒和结核病:致命的人类综合征。
Clin Microbiol Rev. 2011 Apr;24(2):351-76. doi: 10.1128/CMR.00042-10.
2
Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector.公立结核病医院耐多药结核病患者的治疗结果和死亡率。
J Korean Med Sci. 2011 Jan;26(1):33-41. doi: 10.3346/jkms.2011.26.1.33. Epub 2010 Dec 22.
3
Rapid molecular detection of tuberculosis and rifampin resistance.快速分子检测结核分枝杆菌及利福平耐药性。
N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.
4
Drug-resistant tuberculosis: past, present, future.耐药结核病:过去、现在和未来。
Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19.
5
The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey.韩国的结核/人类免疫缺陷病毒(TB/HIV)负担和特征:基于人群数据库和调查的研究。
BMC Infect Dis. 2010 Mar 12;10:66. doi: 10.1186/1471-2334-10-66.
6
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review.HIV感染是耐多药结核病的一个危险因素吗?一项系统评价。
PLoS One. 2009;4(5):e5561. doi: 10.1371/journal.pone.0005561. Epub 2009 May 15.
7
The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.结核分枝杆菌耐药性的演变:从一个耐利福平单药的菌群发展为HIV血清阳性人群中越来越多的耐多药变异株。
J Infect Dis. 2008 Jul 1;198(1):90-4. doi: 10.1086/588822.
8
Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence.一种低适应性耐药结核分枝杆菌菌株在人类免疫缺陷病毒高流行环境中的传播。
J Clin Microbiol. 2008 Apr;46(4):1514-6. doi: 10.1128/JCM.01938-07. Epub 2008 Feb 13.
9
The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results.痰培养阳性的肺结核患者开始抗结核治疗至获得药敏试验结果的间隔时间。
J Korean Med Sci. 2007 Feb;22(1):26-9. doi: 10.3346/jkms.2007.22.1.26.
10
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.广泛耐药结核病是南非农村地区结核病与艾滋病毒合并感染患者的死因之一。
Lancet. 2006 Nov 4;368(9547):1575-80. doi: 10.1016/S0140-6736(06)69573-1.

韩国人免疫缺陷病毒/结核分枝杆菌合并感染患者中耐多药结核病的比例。

Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea.

机构信息

Department of Internal Medicine, National Medical Center, Seoul, Korea.

出版信息

J Korean Med Sci. 2012 Oct;27(10):1143-6. doi: 10.3346/jkms.2012.27.10.1143. Epub 2012 Oct 2.

DOI:10.3346/jkms.2012.27.10.1143
PMID:23091309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3468748/
Abstract

Much controversy surrounds the issue of whether HIV infection is a risk factor for developing multidrug-resistant tuberculosis (MDR-TB). In this study, we evaluated the prevalence of and risk factors for MDR-TB in HIV-infected patients at the National Medical Center of Korea. We reviewed the medical records of HIV/TB co-infected patients from January 2005 to May 2011; the drug susceptibility profiles were available for 55 patients. Of these, 32.7% had MDR-TB, which was approximately 3.6 times higher than the prevalence among the general population. Additionally, there were more additional AIDS-defining clinical illnesses in the MDR-TB group than in the non-MDR-TB group (27.8% vs 5.4%, P = 0.032). These results suggest that HIV infection and HIV-related immunosuppresion may contribute to the development of MDR-TB.

摘要

围绕 HIV 感染是否是耐多药结核病(MDR-TB)发展的危险因素,存在着诸多争议。在本研究中,我们评估了韩国国立医疗中心的 HIV 感染患者中 MDR-TB 的流行率和危险因素。我们回顾了 2005 年 1 月至 2011 年 5 月期间 HIV/TB 合并感染患者的病历;其中 55 例患者的药敏谱可用。在这些患者中,32.7%患有 MDR-TB,这一比例大约是普通人群的 3.6 倍。此外,MDR-TB 组比非 MDR-TB 组有更多的艾滋病定义性临床疾病(27.8% vs 5.4%,P = 0.032)。这些结果表明,HIV 感染和 HIV 相关的免疫抑制可能导致 MDR-TB 的发生。